<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>revista-medicina-scolara</PublisherName>
<JournalTitle>The Journal of School and University Medicine</JournalTitle>
<PISSN/>
<EISSN/>
<Volume-Issue>Volume 10, Issue 1</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season> January-March 2023</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Medical</ArticleType>
<ArticleTitle>THE IMPACT OF COVID-19 CONCERNING THE CENTRAL NERVOUS SYSTEM</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>13</FirstPage>
<LastPage>17</LastPage>
<AuthorList>
<Author>
<FirstName>Madalina</FirstName>
<LastName>Stetca</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Andreea</FirstName>
<LastName>Ördög</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName> Nicoleta</FirstName>
<LastName>Tohanean</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI>10.51546/JSUM.2023.10102</DOI>
<Abstract>Since the beginning of the pandemic, emerging information regarding manifestations of the infection with Sars-Cov-2 virus has been laid out, mainly involving the respiratory consequences as it impacts profoundly the global death rates. In February 2020, first publications that sustain the theory the virus could also possess neuroinvasive potential, have been reported. Until present, there is consistent evidence on the consequences over the CNS (central nervous system) and PNS (peripheral nervous system). To shed light over the central nervous system implications, this paper aims to review some of the clinical entities involved.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>COVID-19, central nervous system</Keywords>
<URLs>
<Abstract>https://revista-medicina-scolara.ro/ubijournal-v1copy/journals/abstract.php?article_id=14409&title=THE IMPACT OF COVID-19 CONCERNING THE CENTRAL NERVOUS SYSTEM</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>1. Divani AA, Andalib S, Biller J, Napoli DM, Moghimi N, Rubinos CA, et al. Central Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2020 Dec 1;20(12).
2. Chen R, Wang K, Yu J, Howard D, French L, Chen Z, et al. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front Neurol. 2021 Jan 20;11.
3. Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021 Sep 1;268(9):3059–71.
4. Alomari SO, Abou-mrad Z, Bydon A. COVID-19 and the central nervous system. Clin Neurol Neurosurg. 2020;198(July):106116.
5. Favas TT, Dev P, Chaurasia RN, Chakravarty K, Mishra R, Joshi D, et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020 Dec 1;41(12):3437–70.
6. Belvis R. Headaches During COVID-19: My Clinical Case and Review of the Literature. Headache. 2020 Jul 1;60(7):1422–6.
7. Kong Z, Wang J, Li T, Zhang Z, Jian J. 2019 novel coronavirus pneumonia with onset of dizziness: a case report. Ann Transl Med. 2020 Apr;8(7):506–506.
8. Cipriani G, Danti S, Nuti A, Carlesi C, Lucetti C, Di Fiorino M. A complication of coronavirus disease 2019: delirium. Acta Neurol Belg. 2020 Aug 1;120(4):927–32.
9. Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C1–11.
10. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708–20.
11. Romero-Sand;aacute;nchez CM, Dand;iacute;az-Maroto I, Fernand;aacute;ndez-Dand;iacute;az E, Sand;aacute;nchez-Larsen and;Aacute;, Layos-Romero A, Garcand;iacute;a-Garcand;iacute;a J, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020 Aug 25;95(8):E1060–70.
12. Koralnik IJ, Tyler KL. COVID-19: A Global Threat to the Nervous System. Ann Neurol. 2020;88(1):1–11.
13. Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020 Aug 1;91(8):889–91.
14. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020 May 14;382(20):e60.
15. Narula, N., Joseph, R., Katyal, N., Daouk, A., Acharya, S., Avula, A., and; Maroun, R. (2020). Seizure and COVID-19: Association and review of potential mechanism. Neurology, Psychiatry and Brain Research, 38, 49–53.
16. Nikbakht, F., Mohammadkhanizadeh, A., and; Mohammadi, E. (2020). How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Multiple Sclerosis and Related Disorders, 46, 102535.
17. Najjar, S., Najjar, A., Chong, D.J. et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 17, 231 (2020).
18. Chiumello D, Bonifazi M. Does the COVID–19 related respiratory failure have a neurogenic component? In: Priori A, editor. NEUROLOGY OF COVID–19 [Internet]. Milano: Milano University Press; 2021 Feb. Chapter 3.</References>
</References>
</Journal>
</Article>
</ArticleSet>